Gastroretentive Drug Delivery Systems Outsourcing Market Growth Outlook Through 2024-2033

Gastroretentive drug delivery systems outsourcing refers to the practice of pharmaceutical companies contracting with external service providers or contract research organizations (CROs) to develop and manufacture drug delivery systems designed to prolong the residence time of medications within the gastrointestinal (GI) tract. These systems are engineered to enhance drug absorption, improve therapeutic efficacy, and optimize patient outcomes.

Sizing and Forecast
The gastroretentive drug delivery systems outsourcing market size has grown strongly in recent years. It will grow from $1.29 billion in 2023 to $1.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the rising incidence of stomach and small intestine disorders, rising drug delivery systems, rising prevalence of gastric cancer, rise in government initiatives, and increase in the number of hospitals.

The gastroretentive drug delivery systems outsourcing market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increase in the number of ambulatory centers, the focus on patient compliance and convenience, the rising incidence of chronic diseases, increasing personalized medicine, and the growing aging population. Major trends in the forecast period include advancements in polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the development of gastroretentive dosage forms, the integration of digital health technologies, smart gastroretentive systems, and targeted drug delivery.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

Segmentation & Regional Insights
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –

1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

Major Driver Impacting Market Growth
The rising prevalence of gastrointestinal disorders is expected to propel the growth of the gastroretentive drug delivery systems outsourcing market going forward. Gastrointestinal disorders refer to a wide range of diseases affecting the digestive tract, which includes the stomach, liver, gallbladder, intestines, and pancreas. Gastrointestinal disorders are rising due to aging populations, antibiotic use, infectious agents, dietary changes, stress and lifestyle factors, and obesity. Outsourcing gastroretentive drug delivery systems provides pharmaceutical companies with the resources and expertise needed to address the growing burden of gastrointestinal disorders, ultimately improving patient outcomes and quality of life. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD), a nonprofit education and research organization, it’s estimated that 5–10% of the global population and 25–45 million people in the U.S. have Irritable bowel syndrome (IBS), a common functional gastrointestinal disorder, which accounts for 20–40% of gastroenterologist visits, significantly impacting individuals and healthcare resources. Therefore, the rising prevalence of gastrointestinal disorders is driving the gastroretentive drug delivery systems outsourcing market.

Key Industry Players
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

The gastroretentive drug delivery systems outsourcing market report table of contents includes:

1. Executive Summary
2. Gastroretentive Drug Delivery Systems Outsourcing Market Characteristics
3. Gastroretentive Drug Delivery Systems Outsourcing Market Trends And Strategies
4. Gastroretentive Drug Delivery Systems Outsourcing Market – Macro Economic Scenario
5. Global Gastroretentive Drug Delivery Systems Outsourcing Market Size and Growth
.
.
.
32. Global Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Benchmarking
33. Global Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Gastroretentive Drug Delivery Systems Outsourcing Market
35. Gastroretentive Drug Delivery Systems Outsourcing Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On: 
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model